TRICIA GREER: Open Payments
NPI 1518336445 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,588 in 239 payments from 20 companies in 2025. Trend: 2023 $3,018 · 2024 $3,988 · 2025 $4,588
Food & beverage: $4,588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $1,068 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $479 |
| Janssen Biotech, Inc. | 31 | $436 |
| Madrigal Pharmaceuticals | 14 | $314 |
| QOL Medical, LLC | 11 | $303 |
| GENZYME CORPORATION | 13 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $281 |
| Regeneron Healthcare Solutions, Inc. | 11 | $273 |
| Phathom Pharmaceuticals, Inc. | 16 | $218 |
| Ardelyx, Inc. | 12 | $199 |
Products named: DUPIXENT, RINVOQ, TREMFYA, XIFAXAN, REZDIFFRA, Sucraid, LINZESS, ENTYVIO.
Industry payments across KY — which companies pay providers there.
